Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan()

BACKGROUND: Marketing authorization holders (MAHs) are obligated to report adverse events (AEs) within 15 days (some cases 30 days) to the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan. METHODS: To analyze the timeliness of AE reporting to the PMDA, 6610 reports for five categories of c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:EBioMedicine
Autores principales: Handa, Nobuhiro, Ishii, Kensuke, Matsui, Yutaka, Ando, Yuki
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4588369/
https://ncbi.nlm.nih.gov/pubmed/26501120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2015.07.011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares